Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Nuvation Bio (NUVB-WT) Change in Interest Receivables (2023 - 2025)

Nuvation Bio (NUVB-WT) has disclosed Change in Interest Receivables for 3 consecutive years, with -$2.2 million as the latest value for Q4 2025.

  • Quarterly Change in Interest Receivables fell 294.02% to -$2.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$285000.0 through Dec 2025, down 115.91% year-over-year, with the annual reading at -$285000.0 for FY2025, 115.91% down from the prior year.
  • Change in Interest Receivables for Q4 2025 was -$2.2 million at Nuvation Bio, down from $1.5 million in the prior quarter.
  • The five-year high for Change in Interest Receivables was $1.5 million in Q3 2025, with the low at -$2.2 million in Q4 2025.
  • Average Change in Interest Receivables over 3 years is $66666.7, with a median of $241500.0 recorded in 2023.
  • Peak annual rise in Change in Interest Receivables hit 529.8% in 2025, while the deepest fall reached 294.02% in 2025.
  • Over 3 years, Change in Interest Receivables stood at $669000.0 in 2023, then crashed by 185.05% to -$569000.0 in 2024, then plummeted by 294.02% to -$2.2 million in 2025.
  • According to Business Quant data, Change in Interest Receivables over the past three periods came in at -$2.2 million, $1.5 million, and -$1.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.